Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells von Markovska, A., Somers, K., Guillaume, J., Melief, J., Mazar, A. P., Schmitt, D. M., Schipper, H. S., Boes, M.

Volltext

PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe von Severin, G. W., Fonslet, J., Kristensen, L. K., Nielsen, C. H., Jensen, A. I., Kjær, A., Mazar, A. P., Johnston, K., Köster, U.

Volltext

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224) von Doñate, F, Juarez, J C, Burnett, M E, Manuia, M M, Guan, X, Shaw, D E, Smith, E L P, Timucin, C, Braunstein, M J, Batuman, O A, Mazar, A P

Volltext

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer von Mazar, Andrew P

Volltext

Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer von Boonstra, M.C, Van Driel, P.B.A.A, Keereweer, S, Prevoo, H.A.J.M, Stammes, M.A, Baart, V.M, Löwik, C.W.G.M, Mazar, A.P, van de Velde, C.J.H, Vahrmeijer, A.L, Sier, C.F.M

Volltext

Structural requirements for the growth factor activity of the amino-terminal domain of urokinase von RABBANI, SA, MAZAR, AP, BERNIER, SM, HAQ, M, BOLIVAR, HENKIN, J, GOLTZMAN, D

Volltext

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours von Cianfrocca, M E, Kimmel, K A, Gallo, J, Cardoso, T, Brown, M M, Hudes, G, Lewis, N, Weiner, L, Lam, G N, Brown, S C, Shaw, D E, Mazar, A P, Cohen, R B

Volltext

Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA) von Rabbani, Shafaat, Harakidas, Penelope, Davidson, Donald J., Henkin, Jack, Mazar, Andrew P.

Volltext

Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell Interaction von Tarui, Takehiko, Mazar, Andrew P., Cines, Douglas B., Takada, Yoshikazu

Volltext

The urokinase plasminogen activator system in cancer : Implications for tumor angiogenesis and metastasis von MAZAR, A. P, HENKIN, J, GOLDFARB, R. H

Volltext

Solution Structure of the Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator von Hansen, Andrew P, Petros, Andrew M, Meadows, Robert P, Nettesheim, David G, Mazar, Andrew P, Olejniczak, Edward T, Xu, Robert X, Pederson, Terry M, Henkin, Jack, Fesik, Stephen W

Volltext

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells von Markovska, A, Somers, K, Guillaume, J, Melief, J, Mazar, A P, Schmitt, D M, Schipper, H S, Boes, M

Volltext

A Peptide Derived from the Non-Receptor-Binding Region of Urokinase Plasminogen Activator Inhibits Glioblastoma Growth and Angiogenesis in vivo in Combination with Cisplatin von Mishima, Kazuhiko, Mazar, Andrew P., Gown, Allen, Skelly, Marilyn, Ji, Xiang-Dong, Wang, Xu-Dong, Jones, Terence R., Cavenee, Webster K., H.-J. Su Huang

Volltext

A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells von Hansen, Andrew P, Petros, Andrew M, Mazar, Andrew P, Pederson, Terry M, Rueter, Annemarie, Fesik, Stephen W

Volltext

Fibrin turnover in lung inflammation and neoplasia von IDELL, Steven, MAZAR, Andrew P, BITTERMAN, Peter, MOHLA, Suresh, HARABIN, Andrea L

Volltext

Angiogenesis blockade as a new therapeutic approach to experimental colitis von Danese, Silvio, Sans, Miquel, Spencer, David M, Beck, Ivy, Doñate, Fernando, Plunkett, Marian L, de la Motte, Carol, Redline, Raymond, Shaw, David E, Levine, Alan D, Mazar, Andrew P, Fiocchi, Claudio

Volltext

PET in vivo generators 134 Ce and 140 Nd on an internalizing monoclonal antibody probe von Severin, G W, Fonslet, J, Kristensen, L K, Nielsen, C H, Jensen, A I, Kjær, A, Mazar, A P, Johnston, K, Köster, U

Volltext

Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase von Rabbani, Shafaat A., Gladu, Julienne, Mazar, Andrew P., Henkin, Jack, Goltzman, David

Volltext

Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor von Huai, Qing, Mazar, Andrew P, Kuo, Alice, Parry, Graham C, Shaw, David E, Callahan, Jennifer, Li, Yongdong, Yuan, Cai, Bian, Chuanbing, Chen, Liqing, Furie, Bruce, Furie, Barbara C, Cines, Douglas B, Huang, Mingdong

Volltext

A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo von Guo, Yongjing, Higazi, Abd Al‐Roof, Arakelian, Ani, Sachais, Bruce S., Cines, Douglas, Goldfarb, Ronald H., Jones, Terence R., Kwaan, H., Mazar, Andrew P., Rabbani, Shafaat A.

Volltext